m.serrano
Submits third-party assay reports on material purchased directly. Based in Dhaka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.35%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043036 | Semaglutide | KP | KP-2601-K5213 | Kestrel | 2026-Q2 | 99.83 | 5.82 | 101.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041731 | TB-500 | TFS | TFS-{CAT}-9979 | Janoshik | 2026-Q1 | 99.35 | 3.97 | 97.0 | Buyer-sourced | 0 | PASS |
| AX-2026-042819 | Melanotan II | GGPeps | GGPE-2509-H1678 | Janoshik | 2026-Q1 | 98.84 | 5.02 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042555 | Tirzepatide | HJ | HJ-2508-P6487 | Kestrel | 2026-Q1 | 99.59 | 4.34 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042372 | Semax | Homopeptide | HOMO-2601-D3090 | Janoshik | 2026-Q1 | 98.89 | 6.58 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020379 | PT-141 (Bremelanotide) | MKM | MKM-2509-B4043 | Janoshik | 2025-Q4 | 99.77 | 6.11 | 100.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018714 | TB-500 | QSC | QSC-2507-J6496 | Kestrel | 2025-Q4 | 99.93 | 6.16 | 94.6 | Buyer-sourced | 1 | FAIL |
| AX-2025-020148 | MOTS-c | ERP | ERP-2508-M9453 | Medutest | 2025-Q3 | 99.25 | 2.07 | 97.9 | Buyer-sourced | 1 | FAIL |
| AX-2024-005020 | IGF-1 LR3 | KP | KP-2406-K5300 | PeptideMeter | 2024-Q3 | 98.11 | 6.52 | 109.0 | Buyer-sourced | 0 | PASS |